Company Profile
Kerecis, the medical fish-skin company
Company Overview
Who We Are
From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions. We provide our customers with innovative digital tools for managing their business that include the use artificial intelligence (AI) to support insurance billing.
We have regional headquarters in the United States, Iceland, and Germany with a workforce of nearly 600 employees worldwide.
Kerecis is part of Coloplast A/S.
Company History
Our History, Founder and Founding Team Members
The Kerecis story began in 2007, when the company founder Fertram Sigurjonsson began entrepreneurial projects in the medical devices field. During his career in several medical device companies, Fertram had built a deep understanding of the industry’s value chain and developed interest in diabetic wounds and human-tissue trauma.
Building on his experience, ranging from software solutions at his startup in Denmark, to the development and commercialization of medical devices for human tissue repair as an employee within two medical device companies, coupled with his youth experience in the fishing village of Isafjordur, Fertram came up with the concept of using fish skin to heal damaged tissue.
Over the initial years of Kerecis, Fertram sought support from former colleagues he had worked with during his career. The colleagues included medical doctors Baldur Tumi Baldursson and Hilmar Kjartansson, U.S. patent attorney Ernest Kenney and lawyer Baldvin Bjorn Haraldsson. Fertram’s father, Sigurjon N. Olafsson, Associate Professor of Chemistry at the University of Iceland and Fertram’s wife Fanney, a biotech engineer with background in pharmaceutical regulatory affairs, were also involved.
In August 2023 Kerecis became Iceland’s first Unicorn when it sold to the Danish company Coloplast for $1.3 billion.
Notable Products / Brands
MariGen, MariGen Shield, SurgiClose, SurgiBind, GraftGuide
Notable Accomplishments / Recognition
In August 2023 Kerecis became Iceland’s first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.